167 related articles for article (PubMed ID: 28499338)
1. Hyaluronic Acid Molecular Weight-Dependent Modulation of Mucin Nanostructure for Potential Mucosal Therapeutic Applications.
Hansen IM; Ebbesen MF; Kaspersen L; Thomsen T; Bienk K; Cai Y; Malle BM; Howard KA
Mol Pharm; 2017 Jul; 14(7):2359-2367. PubMed ID: 28499338
[TBL] [Abstract][Full Text] [Related]
2. Effects of cross-linking molecular weights in a hyaluronic acid-poly(ethylene oxide) hydrogel network on its properties.
Noh I; Kim GW; Choi YJ; Kim MS; Park Y; Lee KB; Kim IS; Hwang SJ; Tae G
Biomed Mater; 2006 Sep; 1(3):116-23. PubMed ID: 18458391
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid-coated chitosan nanoparticles: molecular weight-dependent effects on morphology and hyaluronic acid presentation.
Almalik A; Donno R; Cadman CJ; Cellesi F; Day PJ; Tirelli N
J Control Release; 2013 Dec; 172(3):1142-50. PubMed ID: 24103813
[TBL] [Abstract][Full Text] [Related]
4. Spatial configuration and composition of charge modulates transport into a mucin hydrogel barrier.
Li LD; Crouzier T; Sarkar A; Dunphy L; Han J; Ribbeck K
Biophys J; 2013 Sep; 105(6):1357-65. PubMed ID: 24047986
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid nanoparticles titrate the viscoelastic properties of viscosupplements.
Fakhari A; Phan Q; Thakkar SV; Middaugh CR; Berkland C
Langmuir; 2013 Apr; 29(17):5123-31. PubMed ID: 23514620
[TBL] [Abstract][Full Text] [Related]
6. Disassembling the complexity of mucus barriers to develop a fast screening tool for early drug discovery.
Pacheco DP; Butnarasu CS; Briatico Vangosa F; Pastorino L; Visai L; Visentin S; Petrini P
J Mater Chem B; 2019 Aug; 7(32):4940-4952. PubMed ID: 31411620
[TBL] [Abstract][Full Text] [Related]
7. A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties.
Mayol L; Quaglia F; Borzacchiello A; Ambrosio L; La Rotonda MI
Eur J Pharm Biopharm; 2008 Sep; 70(1):199-206. PubMed ID: 18644705
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of modified hyaluronic acid in terms of rheology, enzymatic degradation and mucoadhesion.
Laffleur F; Netsomboon K; Erman L; Partenhauser A
Int J Biol Macromol; 2019 Feb; 123():1204-1210. PubMed ID: 30465836
[TBL] [Abstract][Full Text] [Related]
9. Mucus barrier-triggered disassembly of siRNA nanocarriers.
Thomsen TB; Li L; Howard KA
Nanoscale; 2014 Nov; 6(21):12547-54. PubMed ID: 25179224
[TBL] [Abstract][Full Text] [Related]
10. A rational approach to form disulfide linked mucin hydrogels.
Joyner K; Song D; Hawkins RF; Silcott RD; Duncan GA
Soft Matter; 2019 Dec; 15(47):9632-9639. PubMed ID: 31651920
[TBL] [Abstract][Full Text] [Related]
11. Characterization of low-molecular-weight hyaluronic acid-based hydrogel and differential stem cell responses in the hydrogel microenvironments.
Kim J; Park Y; Tae G; Lee KB; Hwang CM; Hwang SJ; Kim IS; Noh I; Sun K
J Biomed Mater Res A; 2009 Mar; 88(4):967-75. PubMed ID: 18384163
[TBL] [Abstract][Full Text] [Related]
12. Interaction of hyaluronic acid with mucin, evaluated by gel permeation chromatography.
Saso L; Bonanni G; Grippa E; Gatto MT; Leone MG; Silvestrini B
Res Commun Mol Pathol Pharmacol; 1999; 104(3):277-84. PubMed ID: 10741378
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier.
Pereira de Sousa I; Cattoz B; Wilcox MD; Griffiths PC; Dalgliesh R; Rogers S; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):257-64. PubMed ID: 25661320
[TBL] [Abstract][Full Text] [Related]
14. Barrier properties of gastrointestinal mucus to nanoparticle transport.
Crater JS; Carrier RL
Macromol Biosci; 2010 Dec; 10(12):1473-83. PubMed ID: 20857389
[TBL] [Abstract][Full Text] [Related]
15. Effect of preparation parameters on ultra low molecular weight chitosan/hyaluronic acid nanoparticles.
Nazeri N; Avadi MR; Faramarzi MA; Safarian S; Tavoosidana G; Khoshayand MR; Amani A
Int J Biol Macromol; 2013 Nov; 62():642-6. PubMed ID: 24099942
[TBL] [Abstract][Full Text] [Related]
16. Reversible Condensation of Mucins into Nanoparticles.
Yan H; Chircov C; Zhong X; Winkeljann B; Dobryden I; Nilsson HE; Lieleg O; Claesson PM; Hedberg Y; Crouzier T
Langmuir; 2018 Nov; 34(45):13615-13625. PubMed ID: 30350704
[TBL] [Abstract][Full Text] [Related]
17. Probing the interaction of nanoparticles with mucin for drug delivery applications using dynamic light scattering.
Griffiths PC; Cattoz B; Ibrahim MS; Anuonye JC
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):218-22. PubMed ID: 25986588
[TBL] [Abstract][Full Text] [Related]
18. An experimental and theoretical approach to understand the interaction between particles and mucosal tissues.
Arzi RS; Davidovich-Pinhas M; Cohen N; Sosnik A
Acta Biomater; 2023 Mar; 158():449-462. PubMed ID: 36596435
[TBL] [Abstract][Full Text] [Related]
19. The role of mucus on drug transport and its potential to affect therapeutic outcomes.
Murgia X; Loretz B; Hartwig O; Hittinger M; Lehr CM
Adv Drug Deliv Rev; 2018 Jan; 124():82-97. PubMed ID: 29106910
[TBL] [Abstract][Full Text] [Related]
20. The properties of the mucus barrier, a unique gel--how can nanoparticles cross it?
Pearson JP; Chater PI; Wilcox MD
Ther Deliv; 2016; 7(4):229-44. PubMed ID: 27010985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
